For the children who live in Sahel and sub-Sahel regions of Africa, the rainy season produces a seasonal surge in sickness and death from malaria. Since 2012, the World Health Organization has recommended Seasonal Malaria Chemoprevention (SMC)* as an effective tool to prevent malaria in children under five during the rainy season.
Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel (ACCESS-SMC) is the first project of its kind promoting the scale-up of SMC. Thanks to ACCESS-SMC, a Unitaid-funded project led by Malaria Consortium in partnership with Catholic Relief Services, SMC treatments has been provided to over 6,3 million vulnerable children in seven West African countries.
1. Foster country and community ownership.
2. Reduce risks of misunderstanding and negative perceptions.
3. Ensure adherence to SMC dose completion.